Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
12.65
+0.23 (1.85%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Spyre Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
$50.00
Upside
+295.26%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $45 | Buy | Initiates | $45 | +255.73% | Apr 8, 2025 |
| Jones Trading | Jones Trading | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Dec 11, 2024 |
| Baird | Baird | Buy Maintains $50 → $65 | Buy | Maintains | $50 → $65 | +413.83% | Nov 13, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $50 → $65 | Strong Buy | Maintains | $50 → $65 | +413.83% | Oct 25, 2024 |
| Wedbush | Wedbush | Buy Initiates $45 | Buy | Initiates | $45 | +255.73% | Sep 4, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jul 16, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $35 → $40 | Buy | Maintains | $35 → $40 | +216.21% | May 13, 2024 |
| BTIG | BTIG | Strong Buy Maintains $32 → $40 | Strong Buy | Maintains | $32 → $40 | +216.21% | May 10, 2024 |
| Baird | Baird | Buy Initiates $50 | Buy | Initiates | $50 | +295.26% | May 2, 2024 |
| Stifel | Stifel | Strong Buy Reiterates $36 → $54 | Strong Buy | Reiterates | $36 → $54 | +326.88% | Mar 26, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $12 → $35 | Hold → Buy | Upgrades | $12 → $35 | +176.68% | Mar 1, 2024 |
| BTIG | BTIG | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +152.96% | Dec 20, 2023 |
| Stifel | Stifel | Strong Buy Maintains $23 → $27 | Strong Buy | Maintains | $23 → $27 | +113.44% | Dec 18, 2023 |
| Jefferies | Jefferies | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +145.06% | Dec 11, 2023 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 29, 2023 |